UBS Group’s Motif Bio plc Warrants to Purchase ADRs MTFBW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-127
| Closed | – | – | 8703 |
|
|
2019
Q3 | $0 | Hold |
127
| – | – | ﹤0.01% | 8494 |
|
|
2019
Q2 | $0 | Hold |
127
| – | – | ﹤0.01% | 8403 |
|
|
2019
Q1 | $0 | Sell |
127
-958
| -88% | -$1.61K | ﹤0.01% | 8475 |
|
|
2018
Q4 | $2K | Hold |
1,085
| – | – | ﹤0.01% | 7846 |
|
|
2018
Q3 | $3K | Sell |
1,085
-290
| -21% | -$739 | ﹤0.01% | 7701 |
|
|
2018
Q2 | $3K | Buy |
1,375
+257
| +23% | +$830 | ﹤0.01% | 7685 |
|
|
2018
Q1 | $4K | Buy |
1,118
+120
| +12% | +$502 | ﹤0.01% | 7371 |
|
|
2017
Q4 | $4K | Sell |
998
-212
| -18% | -$881 | ﹤0.01% | 7497 |
|
|
2017
Q3 | $4K | Sell |
1,210
-1,800
| -60% | -$3.98K | ﹤0.01% | 7345 |
|
|
2017
Q2 | $5K | Buy |
3,010
+800
| +36% | +$1.56K | ﹤0.01% | 7160 |
|
|
2017
Q1 | $3K | Buy |
2,210
+2,030
| +1,128% | +$2.86K | ﹤0.01% | 7233 |
|
|
2016
Q4 | $0 | Buy |
+180
| New | +$229 | ﹤0.01% | 8207 |
|
UBS Group's MTFBW Position: Q4 2019 in Review
UBS Group sold out of Motif Bio plc Warrants to Purchase ADRs (MTFBW) in Q4 2019, closing a stake of 127 shares.
UBS Group first reported a position in MTFBW in Q4 2016 and held it in 12 quarters. The position peaked at $5K in Q2 2017. 0 funds tracked by Wall St. Rank hold MTFBW as of Q4 2019.
- UBS Group reported no remaining Motif Bio plc Warrants to Purchase ADRs position as of Q4 2019 after selling out during the quarter.
- UBS Group sold 127 Motif Bio plc Warrants to Purchase ADRs shares in Q4 2019.
- UBS Group first reported a position in Motif Bio plc Warrants to Purchase ADRs in Q4 2016 and held it in 12 quarters.
- UBS Group's Motif Bio plc Warrants to Purchase ADRs position peaked at $5K in Q2 2017.
- 0 funds tracked by Wall St. Rank held Motif Bio plc Warrants to Purchase ADRs as of Q4 2019.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.